Dee Dee Branchaud is in remission, yet she has suffered chronic abdominal pain for years. While invisible to medical tools, the pain has been so intense that she had to stop working at a job she loved. Her experiences, shared in her keynote speech at last year’s Pain in IBD: From Biolog...

Most physicians view pain the way firefighters view smoke, as an urgent alarm that signals an underlying problem. Find and treat the underlying problem and the pain should go away. (That’s why there’s an understandable caution in medicine about anything that might mask pain and make it ...

I was 22 years old when I was first diagnosed with inflammatory bowel disease (IBD). I felt very isolated as a young South Asian American woman, unable to relate to those around me who were healthy and able-bodied. Even though this disease runs in my family, there was very little knowle...

Despite 2020 being a difficult year due to the COVID-19 pandemic, the Foundation saw some great advocacy successes. These could not have been achieved without the efforts of our advocacy volunteers from across the country as well as the leadership of our congressional champions, includi...

On November 17-18, 2020, the Crohn’s & Colitis Foundation hosted its third annual IBD Innovate: Product Development for Crohn’s & Colitis™ conference. This meeting brings together researchers, start-up companies, industry companies, accelerator organizations and more who are com...

On November 17-18, 2020, the Crohn’s & Colitis Foundation hosted its third annual IBD Innovate: Product Development for Crohn’s & Colitis™ conference. This meeting brings together researchers, start-up companies, industry companies, accelerator organizations and more who are com...

Having dietary restrictions is difficult throughout the year, but around the holidays, coping with this challenge becomes even harder. With endless amounts of food being offered by relatives and friends, and nearly every gathering surrounding...

When biosimilars first entered the market five years ago, I was excited about new treatment options for patients and for more competition to be created in the market. In the years since, we have seen seven biosimilars approved by the U.S. Food & Drug Administration for IBD indicatio...

For the past nine years, December 1-7 has been observed across the United States as Crohn’s & Colitis Awareness Week. Originally designated by the passage of U.S. Senate Resolution 199, Awareness Week provides an opportunity for the inflammatory bowel disease (IBD) community to come...